Apotex Health Corp.
APTX.TO
TSX
| 06/30/2026 | |||||
|---|---|---|---|---|---|
| Revenue | -27.68% | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | -27.68% | ||||
| Cost of Revenue | 4.25% | ||||
| Gross Profit | -44.81% | ||||
| SG&A Expenses | 55.67% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | 129.50% | ||||
| Total Operating Expenses | 20.10% | ||||
| Operating Income | -82.27% | ||||
| Income Before Tax | -102.78% | ||||
| Income Tax Expenses | -74.59% | ||||
| Earnings from Continuing Operations | -110.30% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -110.30% | ||||
| EBIT | -82.27% | ||||
| EBITDA | -77.79% | ||||
| EPS Basic | -109.88% | ||||
| Normalized Basic EPS | -96.87% | ||||
| EPS Diluted | -109.88% | ||||
| Normalized Diluted EPS | -96.87% | ||||
| Average Basic Shares Outstanding | 4.22% | ||||
| Average Diluted Shares Outstanding | 4.22% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||